Literature DB >> 17049516

Plasmodium falciparum: a novel method for analyzing haplotypes in mixed infections.

Laura K Certain1, Carol H Sibley.   

Abstract

Studying the population genetics of Plasmodium falciparum is necessary for understanding the spread of drug resistance. However, these studies are hampered by the inability to determine haplotypes from patient samples that contain multiple parasite populations. Therefore, we have developed a method for separating for genetic analysis the individual strains in a mixed infection. We amplified a 6 kb region of chromosome 4, including the dihydrofolate reductase gene and upstream microsatellite markers. This PCR product was inserted by recombination into a gapped yeast shuttle plasmid containing both selectable and counter-selectable markers. Because each plasmid contains only one insert and each yeast colony contains only one plasmid, the individual strains are now separate. We analyzed mixtures of 3D7, K1, and Dd2 DNA and correctly identified a haplotype in each case.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049516      PMCID: PMC1950286          DOI: 10.1016/j.exppara.2006.09.003

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  21 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots.

Authors:  N Sakihama; T Mitamura; A Kaneko; T Horii; K Tanabe
Journal:  Exp Parasitol       Date:  2001-01       Impact factor: 2.011

3.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

4.  In vitro recombination during PCR of Plasmodium falciparum DNA: a potential pitfall in molecular population genetic analysis.

Authors:  Kazuyuki Tanabe; Naoko Sakihama; Anna Färnert; Ingegerd Rooth; Anders Björkman; David Walliker; Lisa Ranford-Cartwright
Journal:  Mol Biochem Parasitol       Date:  2002-07       Impact factor: 1.759

5.  Intercontinental spread of pyrimethamine-resistant malaria.

Authors:  Cally Roper; Richard Pearce; Shalini Nair; Brian Sharp; François Nosten; Tim Anderson
Journal:  Science       Date:  2004-08-20       Impact factor: 47.728

6.  Antifolate antimalarial resistance in southeast Africa: a population-based analysis.

Authors:  Cally Roper; Richard Pearce; Barry Bredenkamp; Jonathan Gumede; Chris Drakeley; Frank Mosha; Daniel Chandramohan; Brian Sharp
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

7.  Linker-mediated recombinational subcloning of large DNA fragments using yeast.

Authors:  Christopher K Raymond; Elizabeth H Sims; Maynard V Olson
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

8.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.

Authors:  John C Wootton; Xiaorong Feng; Michael T Ferdig; Roland A Cooper; Jianbing Mu; Dror I Baruch; Alan J Magill; Xin-Zhuan Su
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

9.  A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites.

Authors:  Shalini Nair; Jeff T Williams; Alan Brockman; Lucy Paiphun; Mayfong Mayxay; Paul N Newton; Jean-Paul Guthmann; Frank M Smithuis; Tran Tinh Hien; Nicholas J White; François Nosten; Tim J C Anderson
Journal:  Mol Biol Evol       Date:  2003-06-27       Impact factor: 16.240

10.  High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier.

Authors:  R H Schiestl; R D Gietz
Journal:  Curr Genet       Date:  1989-12       Impact factor: 3.886

View more
  7 in total

Review 1.  Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review.

Authors:  Shradha Bhullar; Neelima Mishra
Journal:  Parasitol Res       Date:  2022-08-18       Impact factor: 2.383

2.  Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping.

Authors:  Shengfa Liu; Jianbing Mu; Hongying Jiang; Xin-zhuan Su
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

3.  Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Authors:  Laura K Certain; Marnie Briceño; Steven M Kiara; Alexis M Nzila; William M Watkins; Carol Hopkins Sibley
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

Review 4.  Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.

Authors:  Sankar Sridaran; Shannon K McClintock; Luke M Syphard; Karen M Herman; John W Barnwell; Venkatachalam Udhayakumar
Journal:  Malar J       Date:  2010-08-30       Impact factor: 2.979

5.  Functional expression of parasite drug targets and their human orthologs in yeast.

Authors:  Elizabeth Bilsland; Pınar Pir; Alex Gutteridge; Alexander Johns; Ross D King; Stephen G Oliver
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

6.  Isolation of Plasmodium falciparum by flow-cytometry: implications for single-trophozoite genotyping and parasite DNA purification for whole-genome high-throughput sequencing of archival samples.

Authors:  Anne Boissière; Céline Arnathau; Christophe Duperray; Laurence Berry; Laurence Lachaud; François Renaud; Patrick Durand; Franck Prugnolle
Journal:  Malar J       Date:  2012-05-14       Impact factor: 2.979

7.  Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds.

Authors:  Elizabeth Bilsland; Andrew Sparkes; Kevin Williams; Harry J Moss; Michaela de Clare; Pinar Pir; Jem Rowland; Wayne Aubrey; Ron Pateman; Mike Young; Mark Carrington; Ross D King; Stephen G Oliver
Journal:  Open Biol       Date:  2013-02-27       Impact factor: 6.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.